Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Adrenal Glands and Posterior Pituitary Gland: Hormones, Synthesis, Regulation, and Effects, Summaries of Human Physiology

A comprehensive overview of the adrenal glands and posterior pituitary gland, focusing on the hormones they produce, their synthesis, regulation, and effects on the body. It delves into the mechanisms of hormone transport, metabolism, and receptor interactions, offering a detailed explanation of the physiological processes involved. The document also explores the pathophysiology of hormone excess and deficiency, including conditions like cushing's syndrome, addison's disease, and diabetes insipidus. It is an excellent resource for students of biology, medicine, and related fields.

Typology: Summaries

2023/2024

Available from 04/14/2025

chrisdomingoo1120
chrisdomingoo1120 🇵🇭

5 documents

1 / 6

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
ADRENAL GLANDS
Division
HORMONES (type)
TRANSPORT, SYNTHESIS, AND METABOLISM
HYPOTHALAMUS
PITUITARY GLAND
TARGET GLAND
EFFECTS
Adrenal
Cortex
Glucocorticoid -
Cortisol (Steroid) in the
Zona Fasciculata
~80% LDL Cholesterol (also applies to other adrenal
cortex hormones)
1. Receptor-mediated endocytosis (LDLR)
2. Hydrolysis producing free cholesterol (FC)
3. Enters mitochondria via StAR protein
4. FC converted to pregnenolone via
CYP11A1/side chain convertase/desmolase
enzyme
Transport proteins:
1. 90% transcortin (CBG)
2. 7% albumin
3. 3% free
CRH (peptide) - produced by
paraventricular nucleus
Reaches APG via
hypophyseal portal vein then
binds to CRH-R1 in
corticotrophs to produce
ACTH
ACTH (peptide) - produced by
corticotropic cells and binds to
MC2R on adrenal cortex
GPCR → AC → PKA →
Exocytosis
Precursor: Proopiomelanocortin
Enzymes: PC1 and PC2
Products: ACTH, B-lipotropin,
N-terminal protein, Joining protein
ACTH has little effect on
aldosterone synthesis
Main regulator: Angiotensin II,
hyperkalemia
Cortisol
1. binds to glucocorticoid
hormone receptor (GR)
2. HSP90 will dissociate
3. GR enters nucleus
4. binds to DNA
5. transcription and protein
synthesis
Catabolic hormone
1. Increases glucose levels
- Inc. gluconeogenesis
- Dec. glycolysis
2. Mobilization of fats
3. Reduce inflammation by blocking
Phospholipase A2 (blocks prostaglandin and
eicosanoid synthesis)
4. Promotes lipolysis, bone resorption, and
muscle breakdown
Pulsatile release
1. Increased before and upon waking up to
prepare body for stressors
2. Lowest at night when asleep
Mineralocorticoid -
Aldosterone (Steroid)
in the Zona
glomerulosa
Decreased 17-B-HSD activity
Enhanced aldosterone synthase activity
Transport proteins: 60% proteins leading to a
shorter half life than cortisol
Primarily regulates salt and extracellular volume
Increase sodium levels by increasing sodium
reabsorption in the kidneys
Promotes K+ secretion
Androgens (DHEA) in
the Zona reticularis
Enhanced 17, 20 lyase activity
Decreased 21-B hydroxylase activity (
Enhanced DHEA sulfotransferase to produce
DHEAS (prolongs plasma half-life)
Transport proteins: SHBG (has low affinity to albumin
and globulins)
Converted to estrogen and testosterone
Androgens - No feedback
mechanism on CRH and ACTH
Adrenarche - increased adrenal androgen production
1-2 years before puberty
Adrenal
Medulla
Catecholamines:
Epinephrine (80%)
Norepinephrine (20%)
1. Tyrosine (from diet or phenylalanine) → DOPA
via tyrosine hydroxylase
2. DOPA → Dopamine via DOPA decarboxylase
3. Dopamine → NE via dopamine B-hydroxylase
4. NE → E via PNMT
5. Epinephrine is transported back to the granule for
storage
Pretty Tired Doctors Display No Emotion
Metabolism:
1. via COMT and MAO
2. Excreted as Vanillylmandelic acid (VMA) in the
urine
Transported into the chromaffin
granules by VMAT1
(catecholamine-H+ exchanger)
Receptors:
1. Alpha 1 - Gq - vasoconstriction, mydriasis,
bladder constriction
2. Alpha 2 - Gi - inhibits insulin secretion and
ACH and NE release
3. Beta 1 - increased HR (heart) and renin
release ( kidneys)
4. Beta 2 - bronchial smooth muscle dilation
(lungs)
5. Beta 3 - thermogenesis (adipocytes)
PATHOPHYSIOLOGY
Hormone Excess
1. Cushing’s syndrome - glucocorticoid (ACTH-secreting tumors, cortisol-secreting tumor, steroid intake)
a. Moon facies, buffalo hump, hyperglycemia, osteoporosis, recurrent infection
2. Androgen excess in women - Hirsutism, male pattern baldness, clitoral enlargement
3. Chronic steroid intake - mimics cortisol’s negative feedback mechanism = decreased ACTH and CRH
a. Leads to atrophy of zona fasciculata
b. Immediate stopping of steroid intake will lead to adrenal crisis = surge of ACTH and CRH release
4. Hyperaldosteronism - excess aldosterone (not severe due to counter regulatory mechanisms)
a. Hypernatremia
b. Counteracted by ADH
c. Increased ANP release - counteracts aldosterone and ADH
5. Pheochromocytoma - excess catecholamine
a. Chromaffin cell tumor
b. Hypertension, headaches, sweating, palpitations, chest pain
Hormone deficiency
1. Addison’s Disease - primary (adrenal gland defect)
a. Both aldosterone and cortisol are deficient
b. Aldosterone = Hypovolemia hypotension, hyperkalemia
c. Cortisol = weakness, anemia, ileus, hypoglycemia
d. Bronze pigmentation of the skin = due to increased MSH activity
2. Congenital adrenal hyperplasia (CAH)
a. Defect in 21B-OH
b. Low levels of aldosterone and cortisol
c. High levels of androgens
d. Inc. ACTH → hyperplasia → ambiguous genitalia
pf3
pf4
pf5

Partial preview of the text

Download Adrenal Glands and Posterior Pituitary Gland: Hormones, Synthesis, Regulation, and Effects and more Summaries Human Physiology in PDF only on Docsity!

ADRENAL GLANDS

Division HORMONES (type) TRANSPORT, SYNTHESIS, AND METABOLISM HYPOTHALAMUS PITUITARY GLAND TARGET GLAND EFFECTS Adrenal Cortex Glucocorticoid - Cortisol (Steroid) in the Zona Fasciculata ~80% LDL Cholesterol (also applies to other adrenal cortex hormones)

  1. Receptor-mediated endocytosis (LDLR)
  2. Hydrolysis producing free cholesterol (FC)
  3. Enters mitochondria via StAR protein
  4. FC converted to pregnenolone via CYP11A1/side chain convertase/desmolase enzyme Transport proteins:
  5. 90% transcortin (CBG)
  6. 7% albumin
  7. 3% free CRH (peptide) - produced by paraventricular nucleus Reaches APG via hypophyseal portal vein then binds to CRH-R1 in corticotrophs to produce ACTH ACTH (peptide) - produced by corticotropic cells and binds to MC2R on adrenal cortex GPCR → AC → PKA → Exocytosis Precursor: Proopiomelanocortin Enzymes: PC1 and PC Products: ACTH, B-lipotropin, N-terminal protein, Joining protein ACTH has little effect on aldosterone synthesis Main regulator: Angiotensin II, hyperkalemia Cortisol
  8. binds to glucocorticoid hormone receptor (GR)
  9. HSP90 will dissociate
  10. GR enters nucleus
  11. binds to DNA
  12. transcription and protein synthesis Catabolic hormone
  13. Increases glucose levels
  • Inc. gluconeogenesis
  • Dec. glycolysis
  1. Mobilization of fats
  2. Reduce inflammation by blocking Phospholipase A2 (blocks prostaglandin and eicosanoid synthesis)
  3. Promotes lipolysis, bone resorption, and muscle breakdown Pulsatile release
  4. Increased before and upon waking up to prepare body for stressors
  5. Lowest at night when asleep Mineralocorticoid - Aldosterone (Steroid) in the Zona glomerulosa ● Decreased 17-B-HSD activity ● Enhanced aldosterone synthase activity ● Transport proteins: 60% proteins leading to a shorter half life than cortisol Primarily regulates salt and extracellular volume Increase sodium levels by increasing sodium reabsorption in the kidneys Promotes K+ secretion Androgens (DHEA) in the Zona reticularis ● Enhanced 17, 20 lyase activity ● Decreased 21-B hydroxylase activity ( ● Enhanced DHEA sulfotransferase to produce DHEAS (prolongs plasma half-life) Transport proteins: SHBG (has low affinity to albumin and globulins) Converted to estrogen and testosterone Androgens - No feedback mechanism on CRH and ACTH Adrenarche - increased adrenal androgen production 1-2 years before puberty Adrenal Medulla Catecholamines: Epinephrine (80%) Norepinephrine (20%)
  6. Tyrosine (from diet or phenylalanine) → DOPA via tyrosine hydroxylase
  7. DOPA → Dopamine via DOPA decarboxylase
  8. Dopamine → NE via dopamine B-hydroxylase
  9. NE → E via PNMT
  10. Epinephrine is transported back to the granule for storage P retty T ired D octors D isplay N o E motion Metabolism:
  11. via COMT and MAO
  12. Excreted as Vanillylmandelic acid (VMA) in the urine

Transported into the chromaffin

granules by VMAT

(catecholamine-H+ exchanger)

Receptors:

  1. Alpha 1 - Gq - vasoconstriction, mydriasis, bladder constriction
  2. Alpha 2 - Gi - inhibits insulin secretion and ACH and NE release
  3. Beta 1 - increased HR (heart) and renin release ( kidneys)
  4. Beta 2 - bronchial smooth muscle dilation (lungs)
  5. Beta 3 - thermogenesis (adipocytes) PATHOPHYSIOLOGY Hormone Excess
  6. Cushing’s syndrome - glucocorticoid (ACTH-secreting tumors, cortisol-secreting tumor, steroid intake) a. Moon facies, buffalo hump, hyperglycemia, osteoporosis, recurrent infection
  7. Androgen excess in women - Hirsutism, male pattern baldness, clitoral enlargement
  8. Chronic steroid intake - mimics cortisol’s negative feedback mechanism = decreased ACTH and CRH a. Leads to atrophy of zona fasciculata b. Immediate stopping of steroid intake will lead to adrenal crisis = surge of ACTH and CRH release
  9. Hyperaldosteronism - excess aldosterone (not severe due to counter regulatory mechanisms) a. Hypernatremia b. Counteracted by ADH c. Increased ANP release - counteracts aldosterone and ADH
  10. Pheochromocytoma - excess catecholamine a. Chromaffin cell tumor b. Hypertension, headaches, sweating, palpitations, chest pain Hormone deficiency
  11. Addison’s Disease - primary (adrenal gland defect) a. Both aldosterone and cortisol are deficient b. Aldosterone = Hypovolemia hypotension, hyperkalemia c. Cortisol = weakness, anemia, ileus, hypoglycemia d. Bronze pigmentation of the skin = due to increased MSH activity 2. Congenital adrenal hyperplasia (CAH) a. Defect in 21B-OH b. Low levels of aldosterone and cortisol c. High levels of androgens d. Inc. ACTH → hyperplasia → ambiguous genitalia

POSTERIOR PITUITARY GLAND

HORMONE RECEPTOR SYNTHESIS REGULATION EFFECTS PATHOLOGY MANNER OF RELEASE

Vasopressin

ADH

GPCR Neurophysin 1

Precursor: Prepropresophysin →

Propresophysin

Synthesized in the ER and packed into

secretory vesicles in the Golgi apparatus

→ goes to the posterior pituitary

Main: increased plasma osmolarity or

dehydration (>280 mOsm/kg)

Decreased blood pressure/volume

Osmoreceptors are more sensitive than

baroreceptors in detecting changes

Leads to depolarization of magnocellular

neurons → increased ADH release

Increases water reabsorption in the

kidneys

Binds to V2 receptors in DCT and

CT and increases expression of

aquaporin 2

Binds to V1 receptors in vascular

smooth muscles to produce

contraction (PLC pathway)

SIADH - ADH excess

Diabetes insipidus - ADH deficit

  • Neurogenic (brain lesion)
  • Nephrogenic (Aquaporin 2 in

kidneys are mutated)

Oxytocin GPCR Neurophysin 2

Precursor: Preprooxyphysin →

Prooxyphysin

Synthesized in the ER and packed into

secretory vesicles in the Golgi apparatus

→ goes to the posterior pituitary

Distension of the cervix during labor

  • Exerts positive feedback to produce

more oxytocin during delivery

  • Upregulation of oxytocin receptors

and increase in the number of gap

junctions and synthesis of

prostaglandins

Suckling of nipple by the baby

Milk ejection reflex through

contraction of myoepithelial cells

Dilation of cervix during delivery

ANTERIOR PITUITARY GLAND

Growth

Hormone

Cytokine

(JAK-STAT)

GHRH from the hypothalamus

Inhibited by: Somatostatin

Stimulated by: Ghrelin

Other stimulus: Sleep, stress, exercise,

fasting state , AA release

Other inhibitors: glucose, FFA, fed state

Stimulates liver to produce

Somatomedins / IGF-

Postnatal linear growth and

Mitogenic activity

Protein anabolism and promotion of

lipolysis (spares glucose by

switching to lipid oxidation as fuel)

GH excess

  • Gigantism (children) - before
  • Acromegaly (adults) - after

closure of epiphyseal plates

GH deficit

- Dwarfism

  • Laron syndrome (GH

resistant)

Pulsatile bursts

Nocturnal

Gestational: none

Childhood: increasing

Puberty: Peak

Aging: decreasing

Prolactin Cytokine

(JAK-STAT)

PrRP and TRH from the hypothalamus

Suckling of nipple by the baby

Inhibited by: Dopamine and Somatostatin

Stimulated by: Estrogen

Breast development and milk

production

Episodic (during period of suckling

only)

ACTH GPCR (AC) Precursor: Proopiomelanocortin (POMC) Stimulated by fear, infection,

hypoglycemia, surgery, trauma, tumor

Inhibited by: BNP

Stimulated by: ADH

Binds to MC2R in adrenal cortex to

stimulate release of cortisol

Diurnal (2-4 hrs before waking up)

FSH

LH

GPCR (AC) GnRH from the hypothalamus

Stimulated by: Activin, norepinephrine,

estrogen

Inhibited by: Inhibin, dopamine, endorphin,

follistatin

Stimulates the gonads (testis and

ovaries)

Complex

TSH GPCR (AC) TRH from the hypothalamus

Stimulated by: Low T4 and T

Inhibited by: High T4 and T3, dopamine,

somatostatin

Diurnal

ENDOCRINE PANCREAS

HORMONE STRUCTURE TRANSPORT AND SYNTHESIS RECEPTORS SECRETION REGULATION AND METABOLISM EFFECTS

Insulin Anabolic peptide hormone 2 chains (a and b) 51 amino acids 3 disulfide linkages between cysteine residues

  • 2 inter (a and b)
  • 1 intra (a only) From beta cells of pancreas Precursor: Preproinsulin → Proinsulin (5%)
  1. Endoplasmic Reticulum - mRNA transcription and translation of proinsulin
  2. Golgi apparatus - post-translational modification
  3. Cleaved by proinsulinase → Insulin + C peptide* (1:1 ratio)
  4. Stored in secretory granules in Beta cells of pancreas
  • insulin secretion marker because it’s resistant to hepatic metabolism Insulin - highly metabolized in the liver (first pass metabolism) Insulin receptor = tyrosine-kinase (enzyme-linked)
  1. Exists as a dimer
  2. Binding of insulin phosphorylates tyrosine kinase regions
  3. Activation → cellular response Downregulation due to chronic elevated plasma glucose (diabetes):
  4. Increased degradation of receptors
  5. Decreased synthesis of receptors Signal transduction: IRS must be phosphorylated in order to phosphorylate other enzymes to upregulate receptor expression Triggered by:
  6. Glucose
  7. Incretins
  8. Activity/Exercise - SNS
  9. Feeding - PNS (vagal stimulation) Steps of insulin secretion:
  10. Glucose enters B-cell via GLUT- transporter (insulin-independent)
  11. Phosphorylation to G6P via glucokinase (low affinity - not easily saturated)
  12. Glycolysis produces ATP (increases ATP:ADP ratio)
  13. Closure of ATP-sensitive K+ channel
  14. K+ accumulates intracellularly
  15. Depolarization - causes Ca++ channels to open
  16. Ca++ influx promotes exocytosis of secretory granules containing insulin Occurs in two phases: First (preformed and stored) and late (if the first phase was not enough to lower blood glucose) phase - shown as peaks in [plasma insulin] Increases insulin activity: GAFICK
  17. Incretin (AC)
  18. ACh (PLC)
  19. FFAs (PLC)
  20. CCK (PLC)
  21. Glucagon (AC) Decreases insulin activity:
  22. Epinephrine (AC)
  23. Norepinephrine (AC)
  24. Somatostatin (AC) Role in glycolysis
  25. Insulin dephosphorylates kinase activity of bifunctional enzyme
  26. F2,6P is increased
  27. 6-PFK increases glycolysis Role in lipogenesis
  28. Activates ACC
  29. Acetyl-coA → Malonyl-coA Role in muscle glycogenesis
  30. Enhances expression of insulin-dependent GLUT-
  31. Glucose enters myocytes to be stored as glycogen Decreases blood glucose levels Anabolic functions:
  32. Utilization of glucose for ATP:
  33. Storage of FFAs as TAGs
  34. Protein synthesis from AAs
  35. Mitogenic - RNA, DNA synthesis, organelle formation, cell proliferation Target organs:
  36. Liver hepatocytes
  37. Muscle (GLUT-4 translocation)
  38. Adipocytes Increases: Glycolysis, glycogenesis, lipogenesis, protein synthesis Decreases: Gluconeogenesis, glycogenolysis, beta-oxidation (indirectly), proteolysis
  • kinase activity of bifunctional enzyme
  • Acetyl-coa carboxylase (lipogenesis)
  • GLUT-4 transporters in muscles and adipocytes
  • lipoprotein lipase in adipocytes Glucagon Catabolic peptide hormone From alpha cells of pancreas - Majority (centrally located) Precursor: Proglucagon
  1. ER - transcription and translation of proglucagon
  2. Golgi apparatus - post-translational modification
  3. Alpha cells = releases glucagon
  4. Intestinal L cells = releases GLP1 and GLP
  5. Stored in secretory vesicles Glucagon receptor = GPCR (Gs)
  6. AC → cAMP → PKA
  7. PKA phosphorylates key enzymes of gluconeogenesis
  8. Glucose exits the hepatocyte via GLUT- Primarily present in the liver Triggered by:
  9. Main: Ingestion of proteins/AA
  10. Together with insulin, glucagon is increased after a meal, however, insulin increase is much greater than that of glucagon
  11. Catecholamines (sympathoadrenal response) stimulate alpha cells during fasting state Role in glycolysis
  12. Glucagon phosphorylates phosphatase activity of bifunctional enzyme
  13. F6P is increased
  14. F2,6P is decreased
  15. F1,6BP decreases glycolysis Role in Beta-oxidation
  16. No Malonyl-coA = carnitine shuttle is expressed
  17. FFAs enter mitochondria for oxidation Increases blood glucose levels together with GH, Epinephrine, and cortisol (diabetogenic hormones) Target organs:
  18. Liver hepatocytes
  19. Muscle
  20. Adipocytes Increases : Gluconeogenesis, glycogenolysis, beta-oxidation (indirectly), proteolysis, ketogenesis Decreases: Glycolysis, glycogenesis, lipogenesis, protein synthesis Somatostatin Peptide hormone From delta cells of pancreas, D cells of GIT, and hypothalamus Somatostatin receptor = GPCR (Gi)
  21. Inhibits AC
  22. Decreased cAMP
  23. Decreased PKA Inhibits secretion of:
  24. GH
  25. VIP
  26. Insulin, glucagon
  27. Gastrin
  28. VIP
  29. TSH PATHOLOGY Diabetes mellitus 3Ps = Polyphagia, Polydipsia, Polyuria ANTIDIABETIC AGENTS:
  30. ↓ Glucose absorption : a-glucosidase inhibitors, amylin mimetics
  31. ↓ Glucose production: biguanides (metformin), insulin
  32. ↑ Insulin secretion : sulfonylureas, GLP-1 activators, DPP- inhibitors, meglitinides
  33. ↑ Glucose excretion: SGLT2 inhibitors
  34. ↑ Glucose utilization: Insulin, Thiazolidinediones

DIABETIC KETOACIDOSIS

  1. Hyperglycemia
  2. Ketonuria
  3. Ketoacidosis (rise in ketone bodies) → Ketonemia → Metabolic acidosis Causes :
  4. Hormonal imbalance (low insulin/glucagon ratio)
  5. Exaggerates effects of glucagon (inc. ketogenesis) TYPE 1 DM: Insulin-dependent ● Auto-immune ● Beta-cells are destroyed - body cannot produce its own insulin ● There’s a need for exogenous insulin ● Most cases begin in childhood ● Prone to ketosis TYPE 2 DM: Insulin-resistance ● Insulin is enough but the tissues cannot utilize it ● Associated with lifestyle ● More common (90%) Causes:
  6. Chronic elevated blood glucose levels = down regulation of GLUT-4 → decreased uptake of glucose
  7. Decreased repression of hepatic glucose production
  8. Decreased inhibition of HSL, LPL activity in adipocytes

THYROID GLAND

HORMONE STRUCTURE SYNTHESIS TRANSPORT* HALF-LIFE* CONVERSION REGULATION EFFECTS

Triiodothyronine (T3) Active form (10%) A (2 I-) and B (1 I-) ring with 3 residues + MIT + DIT

  1. Trapping - secondary active transport of iodide into the thyroid follicle by Na/I symporter
  2. Transport and Oxidation - transported into the lumen by pendrin and immediately oxidized to iodine via TPO
  3. Iodination - 1-2 iodine molecules will incorporate on the tyrosyl residues of thyroglobulin
  4. Conjugation - coupling of tyrosyl residues to each other via TPO
  5. Endocytosis of iodinated TG back to the follicular cells
  6. Proteolysis of TG to release of T3 and T 99.70% protein-bound 0.3% free Less dominant in the blood 24 hrs (shorter) 1. Type 1 Deiodinase - Liver, kidney, thyroid - T4 → T3 extracellularly (plasma) 2. Type 2 Deiodinase
  • Muscle, CNS, pituitary, placenta, brown fat
  • T4 → T3 intracellularly
  • Important for feedback inhibition 3. Type 3 Deiodinase
  • T4 → rT
  • Inactivation mechanism
  • In response to hyperthyroidism Hypothalamus: TRH
  • Responds to temperature changes Anterior pituitary: TSH
  • Stimulates every aspect of thyroid function Feedback:
  1. T3 and T4 inhibit TRH and TSH release (negative feedback)
  2. Relatively slow process because of their long half-life
  3. Somatostatin and dopamine inhibits TSH secretion Low iodide intake suppresses TPO activity = decreased thyroid synthesis (Wolff-Chaikoff effect)
  4. TH are transported across plasma membrane
  5. Activates nuclear receptors and affect gene description (higher affinity to T3) Effects:
  6. Increases BMR
  7. Increases gluconeogenesis, glycogenolysis
  8. Increase protein synthesis and proteolysis
  9. Increase lipogenesis and lipolysis
  10. Decrease serum cholesterol
  11. Increase brown fat thermogenesis (no ATP yield) “futile cycles”
  12. Increase B-receptors (sensitive to sympathetic response) → Increases HR Thyroxine (T4) Prohormone (90%) A and B ring with 4 iodine residues DIT + DIT 99.98% protein-bound 0.02% free Predominant in the blood 8 days (longest) Reverse T3 (rT3) A (1 I-) and B (2 I-) ring with 3 iodine residues +
  • _In the blood (T3 and T4) :
  1. Thyroid-binding globulin (70%)
  2. Albumin (15-20%)
  3. Transthyretin (10-15%) a. Transport T4 to the CNS_
  • Protein binding extends half-life of hormones in the blood - prevents urine excretion and maintains large circulating reservoir PATHOLOGY HYPERTHYROIDISM
  • Thyroid hormone excess
  • High and active metabolism
  • Increases all aspect of bodily functions HYPOTHYROIDISM
  • Thyroid hormone deficit
  • Slow metabolism
  • Decreases all aspect of bodily functions Goiter - enlarged thyroid gland due to hypo- or hyperthyroidism Grave’s Disease - autoimmune diseases due to hyperthyroidism; characterized by exophthalmos (fat deposition behind the eyeball) Myxedema - non pitting edema due to hypothyroidism; increased mucopolysaccharides Congenital hypothyroidism - cretinism; due to iodine deficiency Hashimoto’s disease - type of hypothyroidism who are not iodine deficient

Leptin

Insulin

a-MSH

● LEP-R = Tyrosine-kinase associated (JAK-STAT)

● Sends anorexigenic signals to the hypothalamus

○ Located in the ventromedial nucleus (satiety center)

○ Based on adiposity

○ Obesity = leptin resistance; increased adiposity but since the body is resistant to leptin, the person will still keep on eating

● Long term (insulin = short term)

● Stimulates : POMC/CART

● Inhibits : AgRP/NYP

● DECREASES FOOD INTAKE (ANOREXIA)

Ghrelin

MCH

● GHSR1a

● Secreted by fundus of stomach

● Sends orexigenic signals to the hypothalamus

○ Located in lateral hypothalamic area (hunger center)

● Stimulate: AgRP/NYP

● Inhibits: POMC/CART

● INCREASES FOOD INTAKE (OREXIA)

OTHER HORMONES OF METABOLISM